A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • AMR.Solutions: Fireside Chat about AMR Benchm...
Media - published on 28 Feb 2022
Share

AMR.Solutions: Fireside Chat about AMR Benchmark Report

The Access to Medicine Foundation's Fatema Rafiqi joined AMR expert John Rex for a 'fireside chat', exploring both the findings of the 2021 Antimicrobial Resistance Benchmark and Fatema's personal journey and career thus far.

Explore further

Media

Millions Miss Out on Antibiotics in Echo of Vaccine Inequity

James Paton writes for Bloomberg Health about the findings of the 2021 Antimicrobial Resistance Benchmark.
Media

Podcast | Drug resistance, not a future problem, it’s here and now: Jayasree Iyer

Jayasree Iyer is the latest guest on the healthcare podcast Pulse, hosted by Jyothi Datta
Publication

2021 Antimicrobial Resistance Benchmark

The third AMR Benchmark is an independent report that compares and analyses how pharmaceutical companies are responding to the crisis of antimicrobial resistance. 

Get in touch

Back to top |